«ДК 021:2015 – 33600000-6 Pharmaceutical products (Amoxicillin and beta-lactamase inhibitor; Clarithromycin; Thiopental; Rocuronium bromide)»

This tender, identified by the CPV code 33600000-6 for Pharmaceutical products, concerns the procurement of several essential medications. The listed items include Amoxicillin and beta-lactamase inhibitor (in film-coated tablets and powder for injection/infusion), Clarithromycin (film-coated tablets), Thiopental, and Rocuronium bromide. The tender explicitly states that by submitting a price proposal, participants confirm that the offered goods do not originate from the Russian Federation, the Republic of Belarus, or the Islamic Republic of Iran. This is a critical compliance requirement. The procurement aims to ensure a stable supply of these vital pharmaceuticals, likely for use in healthcare facilities. The tender specifies different forms and dosages for Amoxicillin/Clavulanic acid, indicating a need for varied therapeutic options. Bidders must ensure their products meet the specified quality standards and comply with the non-origin restrictions. Further details on quantities, delivery schedules, and specific technical requirements are expected in the full tender documentation.

This is a supplies contract in the health and medical services sector, with a focus on Hospitals and Pharmaceuticals. Located in Ukraine, Europe, this opportunity is open to firms and consortiums, with an estimated budget of UAH 550,000.

Published through ProZorro Ukraine, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.